CTF MEG International Services Limited Partnership

CTF MEG International Services Limited Partnership specializes in superconducting magnetoencephalography (MEG) systems. These devices are designed for non-invasive brain imaging, allowing researchers and clinicians to measure and map neural activity by detecting magnetic fields generated by brain function. The focus is on advanced neuroimaging technology for scientific and clinical applications.

The company is based in the United States. While the exact location isn’t specified, its regulatory filings and device listings confirm its operational presence within the US market.

CTF MEG’s devices are listed in the FDA’s Unique Device Identifier (UDI) database. This registry ensures traceability and transparency for Class II medical devices, including the company’s superconducting MEG systems, which fall under this classification in the US.

The company’s superconducting magnetoencephalography systems are classified as Class II medical devices in the US. This classification typically applies to devices that pose moderate risk and require special controls to ensure safety and effectiveness, such as performance standards or post-market surveillance.